Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Joel Lexchin, Professor Emeritus of Health Policy and Management, York University, Canada

How the pharmaceutical industry uses disinformation to undermine drug price reform

The pharma industry warned that if proposed new prescription price guidelines go ahead, drug launches would be delayed and 'Canadian patients will be deprived of potentially life-saving new medicines.' (Shutterstock)

Canada’s drug prices are the fourth highest in the developed world. Despite this, Innovative Medicines Canada (IMC), the lobby group for Big Pharma, put out a call in November 2022 for the Canadian government to suspend consultations on guidelines aimed at lowering prescription drug prices.

The proposed guidelines were expected to come into effect on Jan. 1, but were postponed in late December.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.